Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 4:10:1197745.
doi: 10.3389/fnut.2023.1197745. eCollection 2023.

Association between wine consumption and cancer: a systematic review and meta-analysis

Affiliations
Review

Association between wine consumption and cancer: a systematic review and meta-analysis

Maribel Lucerón-Lucas-Torres et al. Front Nutr. .

Abstract

Background: Alcohol consumption is related to the risk of developing different types of cancer. However, unlike other alcoholic beverages, moderate wine drinking has demonstrated a protective effect on the risk of developing several types of cancer.

Objective: To analyze the association between wine consumption and the risk of developing cancer.

Methods: We searched the MEDLINE (through PubMed), Scopus, Cochrane, and Web of Science databases to conduct this systematic review and meta-analysis. Pooled relative risks (RRs) were calculated using the DerSimonian and Laird methods. I2 was used to evaluate inconsistency, the τ2 test was used to assess heterogeneity, and The Newcastle-Ottawa Quality Assessment Scale were applied to evaluate the risk of bias. This study was previously registered in PROSPERO, with the registration number CRD42022315864.

Results: Seventy-three studies were included in the systematic review, and 26 were included in the meta-analysis. The pooled RR for the effect of wine consumption on the risk of gynecological cancers was 1.03 (95% CI: 0.99, 1.08), that for colorectal cancer was 0.92 (95% CI: 0.82, 1.03), and that for renal cancer was 0.92 (95% CI: 0.81, 1.04). In general, the heterogeneity was substantial.

Conclusion: The study findings reveal no association between wine consumption and the risk of developing any type of cancer. Moreover, wine drinking demonstrated a protective trend regarding the risk of developing pancreatic, skin, lung, and brain cancer as well as cancer in general.

Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022315864, identifier CRD42022315864 (PROSPERO).

Keywords: adult people; alcohol consumption; cancer; systematic review and meta-analysis; wine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram for new systematic reviews including database searches.
Figure 2
Figure 2
Meta-analysis of the association between wine consumption and gynecological cancers. Horizontal lines represent the 95% confidence intervals of the study, and the black boxes represent the effect size of each study.
Figure 3
Figure 3
Funnel plot of the different cancers.
Figure 4
Figure 4
Meta-analysis of the association between wine consumption and colorectal cancer. Horizontal lines represent the 95% confidence intervals of the study, and the black boxes represent the effect size of each study.
Figure 5
Figure 5
Meta-analysis of the association between wine consumption and renal cancer. Horizontal lines represent the 95% confidence intervals of the study, and the black boxes represent the effect size of each study.
Figure 6
Figure 6
Meta-analysis of the association between wine consumption and pancreatic, skin, lung, brain and general cancer. Horizontal lines represent the 95% confidence intervals of the study, and the black boxes represent the effect size of each study.

Comment in

Similar articles

Cited by

References

    1. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. (2018) 392:2052–90. doi: 10.1016/S0140-6736(18)31694-5, PMID: - DOI - PMC - PubMed
    1. Global Burden of Disease 2019 Cancer Collaboration. Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, et al. . Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. (2022) 8:420–44. doi: 10.1001/jamaoncol.2021.6987, PMID: - DOI - PMC - PubMed
    1. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. . Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study [published correction appears in lancet. 2020 Sep 12;396(10253):758]. Lancet. (2020) 395:1907–18. doi: 10.1016/S0140-6736(20)31187-9, PMID: - DOI - PMC - PubMed
    1. GBD 2019 Cancer Risk Factors Collaborators . The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019. Lancet. (2022) 400:563–91. doi: 10.1016/S0140-6736(22)01438-6, PMID: - DOI - PMC - PubMed
    1. Baldewijns MM, van Vlodrop IJ, Schouten LJ, Soetekouw PM, de Bruïne AP, van Engeland M. Genetics and epigenetics of renal cell cancer. Biochim Biophys Acta. (2008) 1785:133–55. doi: 10.1016/j.bbcan.2007.12.002, PMID: - DOI - PubMed

LinkOut - more resources